|
Evaluation of the Bioavailability of Pramlintide Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Evaluation of the Bioavailability of Pramlintide conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Evaluation of the Bioavailability of Pramlintide Clinical research trials and Evaluation of the Bioavailability of Pramlintide healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Evaluation of the Bioavailability of Pramlintide. Evaluation of the Bioavailability of Pramlintide Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Evaluation of the Bioavailability of Pramlintide clinical trial. Human subjects often receive the most effective healthcare possible for their Evaluation of the Bioavailability of Pramlintide condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of the Bioavailability of Pramlintide  Evaluation of the Bioavailability of Pramlintide
Evaluation of the Bioavailability of Pramlintide
For Condition: Diabetes Mellitus, Type 1,Diabetes Mellitus, Type 2
Status: No longer recruiting
Sponsor(s): Amylin Pharmaceuticals ,
Synopsis: This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Placebo Control, Crossover Assignment, Bio-availability Study
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - HbA1c value between 6-12% - BMI <= 27 kg/m2 or BMI >=30 to <= 45 kg/m2 - Consistent insulin regimen for 2 months prior to screening
Total Enrollment:
Location and Contact Information:
DaVita Clinical Research
Minneapolis, Minnesota,
United States
CEDRA Clinical Research, LLC
Austin, Texas,
United States
Orlando Clinical Research Center
Orlando, Florida,
United States
New Orleans Center for Clinical Research
New Orleans, Louisiana,
United States
Additional Information:
Study ID Numbers: 137-153;
Study Start Date: June 2002
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00042471
Other Diabetes Mellitus, Type 2 Studies:
1. Native Hawaiian Diabetes Intervention Program
2. NEW DAY: Nutrition, Exercise, Weight loss, Diabetes And You
3. Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
4. Prevention of Type 2 Diabetes Mellitus in Children
5. Evaluation of the Effect of Pramlintide on Satiety and Food Intake
Related Studies:
Other Diabetes Mellitus, Type 2 Clinical Trials
Other Minnesota Clinical Trials
Other Minneapolis Clinical Trials
Evaluation of the Bioavailability of Pramlintide
|
|
|
|
|
|
|
|
